Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Female outpatients between the ages of 18 and 48 who are:~  * Menstruating~ * Meet criteria for moderate to severe PMS~ * Report PMS symptoms for at least 9 our of the 12 months prior to screening; 4) \*Are using an adequate method of birth control.~Exclusion Criteria:~* Any candidate who:~  * Fulfills MINI (DSM-IV) criteria for a serious AXIS 1 disorder~ * Fulfills DSM-IV criteria during the charting phase consistent with a diagnosis of psychotic disorder, bipolar disorder or major depressive disorder~ * Has a severe, co-existing condition that, in the investigator's opinion, renders the patient unsuitable for the study~ * Poses a significant risk of suicide~ * Takes ongoing medication that could treat PMS symptoms~ * Has a history of hypersensitivity or adverse reaction to fluoxetine or calcium~ * Is lactating, pregnant or is planning to become pregnant during the course of the study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 48 Years
- Healthy Volunteers: f

Study Arms:
- I (Type: ACTIVE_COMPARATOR): Fluoxetine
- II (Type: ACTIVE_COMPARATOR): Calcium
- III (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).